I'm no biomedical guy and an just an ignorant schlub, but I remember hearing similar arguments from Shkreli, that he wasn't making Daraprim inaccessible to the

I'm no biomedical guy and an just an ignorant schlub, but I remember hearing similar arguments from Shkreli, that he wasn't making Daraprim inaccessible to the poor due to things like copays and he was only stiffing the big insurers, and the reason there was so much anger at him was that these big players manipulated the public into doing their bidding. I call bullshit on such arguments honestly, the costs of such schemes do get passed onto the consumers and general public. At the very least such schemes raise insurance prices. I feel this sense of getting pissed on and being told that it's raining. It reminds one of the broader issues of administrative overhead and lack of price discovery in the American healthcare system.